An anti-epilepsy peptide (AEP) was isolated and purified from venom of the scorpion Buthus martensii Karsch. The purification procedure included CM-Sephadex C-50 chromatography, gel filtration on Sephadex G-50 and DEAE-Sephadex A-50 chromatography. Its homogeneity was demonstrated by pH 4.3 polyacrylamide-disc-gel electrophoresis, focusing electrophoresis and SDS/polyacrylamide-disc-gel electrophoresis. The Mr of this peptide, calculated from measurements in SDS/ 15 % -polyacrylamide-discgel and SDS/20 00-polyacrylamide-disc-gel electrophoresis, is 8300. The isoelectric point is 8.52 by pH 8-9.5-range isoelectric focusing. No haemorrhagic or toxic activities were found. No toxicity was found even after the dose reached 28 mg/kg. The pharmacological tests showed that the AEP had no effect on heart rate, blood pressure or electrocardiogram, but strongly inhibited epilepsy induced by coriaria lactone and cephaloridine. The fluorescence spectrum showed that the peptide has a strong emission peak at 337 nm. Amino acid analysis suggested that the AEP is composed of 66 residues from 18 amino acids and has an Mr of 8290. The sequence of the first 50 N-terminal residues is as follows:
INTRODUCTION
Since Miranda and co-workers isolated and purified neurotoxins from venoms of the scorpions Buthus occitanus and Androtonus australis (Miranda et al., 1964a) and studied the relationship between the structure and function of the toxins (Miranda et al., 1964b) , progress in this field has been rapid. So far, at least 50 kinds of mammalian neurotoxins and ten kinds of insect toxins have been purified from scorpion venoms (Tu, 1977; Rochat et al., 1979; Possani, 1984) . The primary and tertiary structures of some toxins as well as the relationship between structure and function have been determined (Fontecilla-Camps et al., 1982; Arseniev et al., 1983; Pashkov et al., 1986) . The mammalian neurotoxins are known to inhibit specifically the Na+ channel, and they have been used to study that Na+ channel (Ovchinnikov & Grishin, 1982) . A proteinase inhibitor that specifically inhibits pepsin and kallikrein, and a histamine-releasing factor that is composed of 33 amino acid residues, have been purified (Chhatwal & Habermann, 1982) . Separation and partial characterization of smooth-muscle-contractile material in the venom of the scorpion Heterometrus bengalensis has also been reported (Kar et al., 1983) .
In China, scorpions have been used in treatment of convulsion and epilepsy by Chinese traditional doctors since the Sung Dynasty (A.D. 960-1279) (Zhou, 1984) . In the past seven years 15 kinds of mammalian neurotoxins have been purified (Zhou, 1983a; Ji & Xu, 1983; Ji et al., 1984; Zhou & Mao, 1985a; Wang & Lei, 1985; Zhou et al., 1988) from venom of the scorpion Buthus martensii Karsch, which is widely distributed in China.
The complete amino acid sequence of one toxin has been determined (Liu et al., 1987) . A hyaluronidase has also been purified from the same species (Zhou & Mao, 1985b) . The present paper describes the first purification of anti-epilepsy peptide (AEP) from venom of the scorpion Buthus martensii Karsch and its subsequent characterization. A comparison of primary structures between AEP and mammalian neurotoxins was also made.
EXPERIMENTAL Materials
Fresh venom from the scorpion Buthus martensii Karsch from China was obtained and freeze-dried as previously described (Zhou, 1983b (1983) . Thirtytwo 170-300 g albino male rats were divided into four groups. The head of each rat was fastened firmly in a head-holder, after being intravenously anaesthetized with sodium pentobarbital. A long midline incision was made in the scalp, the skin was retracted, and the temporal muscles were detached and reflected, exposing the calvarium to be dried. A large part of each temporal lobe was carefully excised. For electroencephalogram recording, two disposable electrodes were made from 1.5 cm lengths of 0.2 mm-diameter needle. When a normal electroencephalogram appeared, the rats in the control group were intramuscularly administered with coriaria lactone (2.5 mg/kg) or cephaloridine (1000 mg/ kg) (Kamei & Tasaka, 1981; Kamei & Sunami, 1983) , and for test groups the rats were intravenously administered with AEP (different doses) or diazepam (7.5 mg/kg) or crude venom (0.3 mg/kg) followed by coriaria lactone (2.5 mg/kg) or cephaloridine (1000 mg/ kg). The inhibitions in the electroencephalograms and individual behaviour were observed carefully.
Determination of protein
Protein concentration was generally determined by the Folin method (Lowry et al., 1951) , with bovine serum albumin as standard. Purification of AEP from venom of Buthus martensii Karsch All operations were carried out at 4-5 'C. All buffers and gel liquids were degassed before use.
(1) CM-Sephadex C-50 column chromatography. A 2 g portion of Buthus martensii venom dissolved in 15 ml of 0.01 M-Na2HPO4/NaH2PO4 buffer, pH 6.4, was centrifuged at 18000 g for 20 min at 4 'C. The soluble venom was chromatographed on a CM-Sephadex C-50 ( 15 cm x 4.5 cm) column equilibrated with the same phosphate buffer. Some 45 % of the protein did not bind to the column. The proteins retained were eluted by a step gradient of NaCl in the phosphate buffer, the elution being done with 1500 ml of 0.25 M-NaCl followed by 1400 ml of 0.5 M-NaCl. The flow rate was 36 mI/h, and 9 ml fractions were collected.
(2) Gel filtration on Sephadex G-50. This was carried out on a column (110 cm x 1.6 cm) of Sephadex G-50 equilibrated with 0.1 M-Na2HPO4/NaH2PO4 buffer, pH 8.0. The fractions of AEP obtained from CMSephadex were freeze-dried to powder and redissolved in 5 ml of distilled water. Five runs were performed, in each of which a 1.0 ml sample was applied and eluted with the same buffer at a flow rate of 20 ml/h. Active fractions were pooled and dialysed against 4 litres of O.O1 M-Na2HPO4/NaH2PO4 buffer, pH 8.0.
(3) DEAE.Sephadex A-50 'olumn chromatography.
The dialysed eluate from the Sephadex-(-50 columnwas applied to a DEAE-Sephadex A-50 column (20 cm x 1.6 cm) equilibrated with 0.01 M-Na2HPO4/ NaH2PO4 buffer, pH 8.0. The sample solution (35 ml) was applied at a flow rate of 24 ml/h to the column, which was eluted with a step gradient of NaCl in the phosphate buffer, elution being done with 120 ml of 0.01 M-NaCl and 50 ml of 0.25 M-NaCl followed by 100 ml of 0.5 M-NaCl. The flow rate was 24 ml/h and 6 ml fractions were collected. Further purification of AEP
(1) Reverse-phase h.p.l.c. on ODS-C18. Freeze-dried AEP, after chromatography on CM-Sephadex C-50, Sephadex G-50 and DEAE-Sephadex A-50, was dissolved in 0.1 % (v/v) trifluoroacetic acid to a concentration of 10 mg/ml and purified further by reversed-phase h.p.l.c. on an ODS-C18 column (4 mm x 200 mm) (LKB Produkter). A 100 ,1 sample was applied to the column, which had previously been equilibrated with 3000 (v/v) Two protein peaks were obtained, of which peak 1 possessed the anti-epileptic activity. Total recovery of protein was 92 %. The preparation was freeze-dried for subsequent study. Amino acid composition Amino acid analysis was carried out essentially as described by Liu & Chang (1971) . The sample was hydrolysed by 2 % (v/v) tryptamine/4 M-toluene-psulphonic acid at 110°C for 24 h and then the preparation was analysed by using a 121-MB Beckman amino acid analyser. Reduction and S-carboxymethylation of AEP This was performed essentially as previously described by Crestfield et al. (1963) .
Determination of N-terminal partial sequence of AEP Reduced and S-carboxymethylated AEP was subjected to Edman automatic sequential degradation (Edman & Begg, 1967) . Portions (10 nmol and 40 nmol) of reduced and S-carboxymethylated AEP were dissolved in 0.2 Macetic acid (30 #1 and 100 ,u1 respectively) and added to Biobrene films, which were applied to the reaction chamber of a model 470-A protein gas-phase sequencer (Applied Biosystems). The phenylthiocarbamoyl-amino acid produced at each cycle was converted automatically and identified in a model 120-A amino acid phenylthiohydantoin analyser (Applied Biosystems Polyacrylamide-slab-gel electrophoresis Polyacrylamide-gel electrophoresis was carried out as described by Davis (1964) . Gel electrophoresis in the presence of SDS was performed on Tris/glycine-buffered 15 0 or 200 (w/v) polyacrylamide slab gels (Anderson et al., 1973) . Gels were stained for protein with Coomassie Brilliant Blue G-250 and for glycoprotein with Schiff reagent (Glossmann & Neville, 1971) .
Isoelectric focusing
This was performed with the electrofocusing gelelectrophoresis system (Haglund, 1971) . The precast gels encompassed the pH ranges 3.5-10 and 8.0-9.5. A mixture of ten standard proteins of pl 3.6-10.2 (FMC Corp., Rockland, ME, U.S.A.) and pure AEP were electrofocused and then stained with Coomassie Brilliant Blue R.
Thermostability
Pure AEP preparations were heated in 0.01 MNa2HPO4/NaH2PO4 buffer, pH 6.4, for 30 min at temperatures from 40 to 80 'C. Relative activity was determined by using the anti-epilepsy assay.
Spectra Absorption spectra of AEP were recorded on a Philips PU 8800 spectrometer, and fluorescence spectra of AEP were recorded on a Hitachi 650-60 fluorescent spectrometer.
Measurement of LD50 and haemorrhagic activity
The LD50 of AEP was measured as previously described by Dixon & Mood (1948) . The determination of haemorrhagic activity was carried out as described by Kondo et al. (1960) .
Effects on heart rate, electrocardiogram, blood pressure and breath rate Rabbits (1.8-2.8 kg) were intravenously anaesthetized with sodium pentobarbital, and then pure AEP was administered intravenously (0.72-1.42 mg/kg). The blood pressure in the common carotid artery was determined with a pressure sensor, the breath rate was determined with a thermocouple sensor, and the ECG was measured. A multipurpose polygraph (made by Nihon Kondon, Japan) was used to record the physiological curves.
RESULTS

Purification of AEP
Of the 18 protein peaks obtained from CM-Sephadex C-50 chromatography, only peaks 1-5 had no toxicity to mice (Fig. 1) , which means most of the toxic proteins or peptides present in the crude venom were cationic at pH 6.4 and did bind to the cation-exchanger resin. AEP activity was in peak 4. It was convenient that this procedure removed toxic fractions. In gel filtration on a Sephadex G-50 column, the position of AEP, which was pooled, was in peak 3 (Fig. 2) , showing that it was a protein with low Mr. AEP was found in peak 1 from DEAE-Sephadex A-50 (Fig. 3) .
The content of AEP in crude venom was low, and only 6.1 mg of pure AEP was obtained from 2000 mg of B. martensii venom. The purification of AEP is summarized in Table 1 , and the protein recovery was typically 0.2-0.5%, representing an apparent purification of 5-8-fold over the active fraction from CM-Sephadex C-50 chromatography (Table 2) . Purified AEP was essentially homogeneous, as judged by pH 8.3 polyacrylamide-slabgel electrophoresis, isoelectric focusing and SDS/ polyacrylamide-gel electrophoresis (Fig. 4) . The material represented in the band in SDS/polyacrylamide-gel electrophoresis stained with Coomassie Brilliant Blue C-250 but did not stain with Schiff reagent. From this result it was concluded that AEP is not a glycoprotein. The freeze-dried venom (2000 mg) was applied to a CM-Sephadex C-50 column as described in the Experimental section.
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-----, NaCl gradient. (Fig. 5) . In size-exclusion h.p.l.c., two protein peaks were obtained, of which peak I had the anti-epilepsy activity with 920 recovery of protein (Fig. 6) , and assay of antiReduction and S-carboxymethylation of AEP. Purified AEP was reduced by dithioerythritol in 6 M-guanidinium chloride and was treated with iodoacetic acid to produce S-carboxymethylated AEP, which was desalted by molecular-sieve h.p.l.c. on a TSK G2000SW column. Table 2 . Biological assay of AEP activity during purification When a normal electroencephalogram appeared, the rats in the control group were intramuscularly administered with 0.01 MNa2HPO4/NaH2PO4 buffer, pH 6.4, followed by coriaria lactone (2.5 mg/kg), and for test groups the rats were intravenously administered with different eluents containing AEP followed by coriaria lactone (2.5 mg/kg). For N-Terminal partial sequence of AEP. By using gasphase automatic degradation with a 470-A sequencer and 120-A amino acid phenylthiohydantoin analyser (Applied Biosystems), the sequence of the first 50 Nterminal residues was determined as shown in Fig. 7 though the calculated value for half-cystine is 4, not 6, 6 cysteine residues were found in sequencing; however, since Cys is difficult to determine in amino acid analysis, it is not unexpected that analysis shows a lower value. So the Mr of AEP is calculated in accordance with 6 half-cystine residues. Leu-Ala-Gln-Asp-Cys-Glu-Gly-Leu-Pro-Asp-Thr method and easy to control. At an adequate dose, epilepsy can be induced in half an hour. But there are no strict one-to-one correlations regarding the electroencephalogram and behaviour, only relative degrees of correlation. We had to choose mean time to seizure, severity of epilepsy, death rate and mean time to recovery as end points. The tests showed that AEP has remarkable effects on inhibition of epilepsy and muscle tic, at least 26 times that of diazepam (P < 0.01) ( Table 4) . As purification of AEP proceeded, its relative activity rose rapidly (Table 2 ).
Toxicity and haemorrhagic activity. The determination of toxicity and haemorrhagic activity of AEP showed that toxicity was not found even after the dose to mice reached 28 mg/kg body wt.
General pharmacological effects on experimental animals. The tests indicated that when animals were intravenously injected with AEP (0.72-1.42mg/kg) the heart rate of the rabbit was decreased by 7 % (P < 0.01) of the original rate, arrhythmia and change of breath rate were not found, and blood pressure was only raised a little; when the animals were ventricularly injected, the heart rate and blood pressure were decreased by 8.8%
(P < 0.05) and 9.40% (P < 0.01) respectively, and there was no effect on breath rate and rhythm.
DISCUSSION
Work on peptides or proteins with anti-epilepsy activity is rare to date. We are the first to report on the AEP from venom of the Chinese scorpion Buthus martensii Karsch.
The experimental model of epilepsy that we chose is a new one. It responds sensitively to drugs and is very convenient to control, so that we obtained reliable results during the assay of AEP. When diazepam was used for comparison, the action of AEP against epilepsy was very strong, i.e. 76 times as strong as diazepam on a molar basis, or 26 times on a weight basis.
Generally speaking, some nerve diseases such as epilepsy and convulsions have definite foci in the brain, and the epilepsy models induced would also be accompanied by some cortical lesions in the brain. If the drug acts against epilepsy, it must have the capability to pass through the blood-brain barrier. In blood, hydrophobic molecules such as 02, CO2 and ethanol can pass through it, but hydrophilic or polar molecules, such as penicillin, cannot do so. The pharmacological tests Lys-Lys-Asn-Gly-Gly-Ser-Ser-Gly-Ser-Ser-Cys-Phe-Leu-Val-Pro-Ser-Gly-Leu-Ala-Cys-Trp-Cys-Lys-AspLys-Lys-Asn-Gly-Gly-Ser-Ser-Gly-Ser-Ser-Cys-Phe-Leu-Val-Pro-Ser-Gly-Leu-Ala-Cys-Trp-Cys-Lys-AspGlu-Cys-Tyr-Lys-Leu-Lys-Gly-Glu-Ser-Gly-Tyr-Cys-Gln-Trp-Ala-Ser-Pro-Tyr-Gly-Asn-Ala-Cys-Tyr-CysLys-Lys-Asn-Gly-Ala-Lys-Ser-Gly-Ser-Cys-Gly-Phe-Lys-Ile-Pro-Ser-Gly-Leu-Ala-Cys-Trp-Cys-Val-AlaLys-Glu-Cys-Arg-Ala-Tyr-Gly-Ala-Ser-Tyr-Gly-Tyr-Cys-Trp-Thr-Val-Lys-Leu-ala-Gln-Asp-Cys-Glu-GlyLeu-Cys-Thr-Asp-Asn-Gly-Ala-Glu-Ser-Gly-Tyr-Cys-Gln-Trp-Val-Gly-Arg-Tyr-Gly-Asn-Ala-Cys-Xaa-CysGlu-Cys-Lys-Lys-Gly-Ala-Glu-Ser-Gly-Lys-Cys-Trp-Tyr-Ala-Gly-Gln-Tyr-Gly-Asn-Ala-Cys-Trp-Cys-TyrGlu-Cys-Thr-Lys-Leu-Lys-Gly-Glu-Ser-Gly-Tyr-Cys-Gln-Trp-Ala-Ser-Pro-Tyr-Gly--Asn-Ala-Cys-Tyr-Cys-50 55 60 AaH I Ji et al. (1983) . § From Wang & Lei (1985) . demonstrated that AEP strongly inhibited normal and epilepsy electroencephalograms by either intravenous or ventricular injection, which means that the AEP must easily penetrate the barrier to act on the brain.
The u.v.-absorption spectrum in our experiment indicated that the AEP has a strong absorption peak at 279 nm, and the fluorescence emission spectrum also indicated that the AEP has an excitation peak at 280 nm and a strong emission peak at 337 nm. From these results it was certain that the AEP contains at least one tryptophan residue, which fits the results of amino acid analysis.
Even though some properties of AEP are similar to those of scorpion toxins, such as Mr, pl and thermostability (Table 5) , there is still a big difference between them. A toxic effect of AEP was not found in mice even after the dose reached 28 mg/kg, and furthermore there are hardly any effects on heart rate, electroencephalogram and breath rate, and only a little effect on blood pressure. Most scorpion toxins have LD50 values in the range 0.5-1.5mg/kg, and tachycardia, arrhythmia and blood pressure increase markedly (Possani, 1984) . Evidently, this remarkable difference in functions depends on different structures, which should be evident in the amino acid sequences of AEP and scorpion toxins. It is a basal characteristic of the toxins that there are eight cysteine residues and no methionine (Possani, 1984) . In AEP there are six cysteine residues and one methionine residue. However, some conserved fragments, such as Asp-Gly-Tyr-Ile, Asn-Cys and Leu-Pro-Asp, do exist in the sequences of AEP and scorpion mammalian toxins (Fig. 8) , suggesting a certain homology between AEP and scorpion toxins. Three of the six cysteine residues of AEP are in the same positions as those of scorpion toxins. However, there are major differences between AEP and the toxins in the N-terminal partial sequence. First of all, the AEP molecule lacks two residues before the conservative sequence Asp-Gly-Tyr-Ile. Secondly, the positions of the other three of the six cysteine residues in the AEP sequence are different from those in toxins, which gives rise to structural diversity. Especially, the AEP molecule lacks a fragment of Cys-Trp/Tyr-Cys, which exists in all the toxins.
